I

Isu Abxis Co Ltd
KOSDAQ:086890

Watchlist Manager
Isu Abxis Co Ltd
KOSDAQ:086890
Watchlist
Price: 4 980 KRW -1.39% Market Closed
Market Cap: 178.8B KRW
Have any thoughts about
Isu Abxis Co Ltd?
Write Note

Isu Abxis Co Ltd
Total Liabilities & Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Isu Abxis Co Ltd
Total Liabilities & Equity Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Liabilities & Equity CAGR 3Y CAGR 5Y CAGR 10Y
I
Isu Abxis Co Ltd
KOSDAQ:086890
Total Liabilities & Equity
â‚©140.6B
CAGR 3-Years
-4%
CAGR 5-Years
6%
CAGR 10-Years
10%
Celltrion Inc
KRX:068270
Total Liabilities & Equity
â‚©19.9T
CAGR 3-Years
56%
CAGR 5-Years
40%
CAGR 10-Years
24%
SK Bioscience Co Ltd
KRX:302440
Total Liabilities & Equity
â‚©1.9T
CAGR 3-Years
49%
CAGR 5-Years
36%
CAGR 10-Years
N/A
H
Hugel Inc
KOSDAQ:145020
Total Liabilities & Equity
â‚©943B
CAGR 3-Years
-2%
CAGR 5-Years
1%
CAGR 10-Years
N/A
P
PharmaResearch Co Ltd
KOSDAQ:214450
Total Liabilities & Equity
â‚©601.5B
CAGR 3-Years
21%
CAGR 5-Years
18%
CAGR 10-Years
N/A
Alteogen Inc
KOSDAQ:196170
Total Liabilities & Equity
â‚©306.3B
CAGR 3-Years
6%
CAGR 5-Years
33%
CAGR 10-Years
N/A
No Stocks Found

Isu Abxis Co Ltd
Glance View

Market Cap
177.6B KRW
Industry
Biotechnology

ISU Abxis Co., Ltd. engages in the provision of pharmaceutical products. The company is headquartered in Seongnam, Gyeonggi-Do and currently employs 143 full-time employees. The company went IPO on 2009-02-03. The firm operates its business under two divisions: antibody therapeutics business division and diagnostic business division. Its antibody therapeutics business division engages in the development of Cloticab, which is a monoclonal therapeutic antibody for thrombus. Its diagnostic business division engages in the provision of genetic testing services and chemotherapy response assay services for cancer examination.

Intrinsic Value
8 552.29 KRW
Undervaluation 42%
Intrinsic Value
Price
I

See Also

What is Isu Abxis Co Ltd's Total Liabilities & Equity?
Total Liabilities & Equity
140.6B KRW

Based on the financial report for Jun 30, 2024, Isu Abxis Co Ltd's Total Liabilities & Equity amounts to 140.6B KRW.

What is Isu Abxis Co Ltd's Total Liabilities & Equity growth rate?
Total Liabilities & Equity CAGR 10Y
10%

Over the last year, the Total Liabilities & Equity growth was 1%. The average annual Total Liabilities & Equity growth rates for Isu Abxis Co Ltd have been -4% over the past three years , 6% over the past five years , and 10% over the past ten years .

Back to Top